… for patients above 40 years with increased risk cardiovascular disease and colorectal cancer
… chemotherapy did not have any survival benefit compared to patients not on digoxin [79]. …

… survival rate of colorectal liver metastases patients after surgical resection is up to 50%, but
only 20% of patients … inhibitor (SNRI) and tricyclic antidepressant (TCA) treat depression. The …

… between tricyclic antidepressant (TCA) prescription and all-cause mortality following …
Survival of glioma and colorectal cancer patients using tricyclic antidepressants post-diagnosis…

… treatment, which extends life in most cases. Unfortunately, tumor recurrence is nearly universal
and patients with recurrent glioblastoma typically survive <1 … approved for use in patients. …

… aspirin in mutated-PIK3CA colorectal cancer patients was associated with better colorectal …
Survival of glioma and colorectal cancer patients using tricyclic antidepressants postdiagnosis…

… of using tricyclic antidepressants for mortality reduction in people with glioma or colorectal
cancer. … , examining the relationship between depression and survival in glioma. However, the …

… in colorectal carcinoma, glioblastoma and breast cancer cell … restricted to colorectal cancer
and breast cancer and caused … tumors are highly dependent on autophagy for survival and …

… survival for glioblastoma patients well enough to receive the standard of care treatment is just
14.6 months post-diagnosis … Clomipramine is a tricyclic antidepressant drug that is effective …

… , 2 publications included serotonin and norepinephrine reuptake inhibitors (SNRIs), 5
publications included tricyclic antidepressants (TCAs), and 7 publications included other atypical …

… worsen overall survival and prognosis in patients with brain … inhibitors (SSRIs), the tricyclic
antidepressants (TCA) and the … of using TCAs for patients with glioma or colorectal cancer. …